Results 251 to 260 of about 93,456 (297)
Mechanisms of Action of Adjuvants [PDF]
Frontiers in Immunology, 2013 Adjuvants are used in many vaccines, but their mechanisms of action are not fully understood. Studies from the past decade on adjuvant mechanisms are slowly revealing the secrets of adjuvant activity. In this review, we have summarized the recent progress in our understanding of the mechanisms of action of adjuvants.
George Mutwiri, Lorne A Babiuk
exaly +6 more sources
Nature Reviews Immunology, 2018 Besides cholesterol lowering, statins boost antigen presentation and adaptive immune responses, suggesting new uses as adjuvants for cancer immunotherapy.
Lucy Bird
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Vaccine, 2005
Induction of immune responses following oral immunization is frequently dependent upon the co-administration of appropriate adjuvants that can initiate and support the transition from innate to adaptive immunity. The three bacterial products with the greatest potential to function as mucosal adjuvants are the ADP-ribosylating enterotoxins (cholera ...
L C, Freytag, J D, Clements
openaire +4 more sources
Induction of immune responses following oral immunization is frequently dependent upon the co-administration of appropriate adjuvants that can initiate and support the transition from innate to adaptive immunity. The three bacterial products with the greatest potential to function as mucosal adjuvants are the ADP-ribosylating enterotoxins (cholera ...
L C, Freytag, J D, Clements
openaire +4 more sources
International Reviews of Immunology, 1990
In summary, HIV vaccine studies described have generally not been designed to measure the effect of the adjuvant or to make comparisons between adjuvants. In only one study was a head-to-head comparison made between HIV antigen alone and antigen formulated with different adjuvants. We hope that future experiments with HIV/SIV vaccine candidates will be
R, Edelman, C O, Tacket
openaire +2 more sources
In summary, HIV vaccine studies described have generally not been designed to measure the effect of the adjuvant or to make comparisons between adjuvants. In only one study was a head-to-head comparison made between HIV antigen alone and antigen formulated with different adjuvants. We hope that future experiments with HIV/SIV vaccine candidates will be
R, Edelman, C O, Tacket
openaire +2 more sources
Thoracic Surgery Clinics, 2020
Five-year survival rates for patients with early-stage non-small cell lung cancer have room for improvement. Adjuvant chemotherapy results in a small but significant increase in overall survival at 5 years. Efforts to improve outcomes by intensifying adjuvant treatment, utilizing cancer-specific vaccines or tyrosine kinase inhibitors in unselected ...
Jessica A, Hellyer, Heather A, Wakelee
openaire +2 more sources
Five-year survival rates for patients with early-stage non-small cell lung cancer have room for improvement. Adjuvant chemotherapy results in a small but significant increase in overall survival at 5 years. Efforts to improve outcomes by intensifying adjuvant treatment, utilizing cancer-specific vaccines or tyrosine kinase inhibitors in unselected ...
Jessica A, Hellyer, Heather A, Wakelee
openaire +2 more sources
Adjuvant activity of incomplete Freund's adjuvant
Advanced Drug Delivery Reviews, 1998The water-in-oil emulsion adjuvants developed by Jules Freund and coworkers have been, and continue to be, used in research and veterinary vaccines. Incomplete Freund's Adjuvant (IFA) has also been widely tested in humans where it was shown to augment antibody responses greater than other adjuvants, such as alum, and to be well tolerated.
, Jensen, , Savary, , Diveley, , Chang
openaire +2 more sources
2018
Developing new vaccines against emerging pathogens or pathogens where variability of antigenic sites presents a challenge, the inclusion of stimulators of the innate immune system is critical to mature the immune response in a way that allows high avidity recognition while preserving the ability to react to drifted serovars. The innate immune system is
Darrick, Carter +2 more
openaire +2 more sources
Developing new vaccines against emerging pathogens or pathogens where variability of antigenic sites presents a challenge, the inclusion of stimulators of the innate immune system is critical to mature the immune response in a way that allows high avidity recognition while preserving the ability to react to drifted serovars. The innate immune system is
Darrick, Carter +2 more
openaire +2 more sources
Current Opinion in Allergy & Clinical Immunology, 2012
This article gives an overview about the current state of preclinical and clinical studies using different kinds of adjuvants and their effect on allergen-specific immunotherapy (SIT).Recently, vectors such as liposomes and microspheres and adjuvants such as Toll-like-receptor agonists [e.g.
Oliver, Pfaar +4 more
openaire +2 more sources
This article gives an overview about the current state of preclinical and clinical studies using different kinds of adjuvants and their effect on allergen-specific immunotherapy (SIT).Recently, vectors such as liposomes and microspheres and adjuvants such as Toll-like-receptor agonists [e.g.
Oliver, Pfaar +4 more
openaire +2 more sources
2009
This chapter focuses on the therapeutic strategies for patients with gliomas other than surgery (Chap. 6) and radiotherapy (Chap. 7). It deals with gliomas of all WHO grades and details the primary treatment as well as therapeutic options at recurrence.
Wick, W, Weller, M
openaire +2 more sources
This chapter focuses on the therapeutic strategies for patients with gliomas other than surgery (Chap. 6) and radiotherapy (Chap. 7). It deals with gliomas of all WHO grades and details the primary treatment as well as therapeutic options at recurrence.
Wick, W, Weller, M
openaire +2 more sources